Tavo, Pembrolizumab Combo May Aid in Reducing Remissions in Advanced Melanoma

The combination of tavo and pembrolizumab was associated with a higher than anticipated response rate in patients with advanced melanoma with low frequencies of checkpoint positive cytotoxic lymphocytes.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news